Skip to content
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
Subscribe
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Calendar
  • About
    • Learn more about BioVox
  • Contact
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands
  • Field of application
    • Agrofood
    • Biomedical/pharma
    • Environment/sustainability
    • Personal/public health
    • Veterinary science
  • Focus on
    • Discovery & research
    • Finance & investment
    • Industrial application
    • Technology & digital innovation
  • Content type
    • Article
    • Interview
    • News
    • Opinion
    • Press release
  • Showcase
    • BioVox
    • Biovia
    • QbD Group
    • V-Bio Ventures
    • SciMingo
    • JnJ Innovative Medicine
  • Regional news
    • Belgium
      • Flanders
      • Wallonia
    • Luxembourg
    • The Netherlands

Press release

  • September 2, 2016

New strategic VIB – BioPontis Alliance for Rare Diseases

  • for BioVox
  • August 29, 2016

Huge steps forward in VIB skin cancer research

  • for BioVox
  • August 23, 2016

Only one stop more for Galapagos to market filgotinib

  • for BioVox
  • August 18, 2016

Increase oxygen to fight cancer

  • for BioVox
  • August 9, 2016

Breakthrough in understanding dystonia

  • for BioVox
  • August 4, 2016

GSK sets foot in bioelectronics

  • for BioVox
  • July 26, 2016

European money for Belgian science!

  • for BioVox
  • July 18, 2016

Making healthcare personal again

  • for BioVox
  • July 14, 2016

The future of healthcare according to Maggie De Block: The cheaper, the better!

  • for BioVox
  • July 14, 2016

The Center of Human Genetics reveals all your secrets

  • for BioVox
  • July 12, 2016

Celyad cuts deal with Ono Pharmaceutical on immunotherapy treatment

  • for BioVox
  • July 12, 2016

Diagnostics for better use of the healthcare budget

  • for BioVox
  • July 5, 2016

VIB-KULeuven/ULB research team discover new cancer target

  • for BioVox
  • July 5, 2016

TiGenix inks massive deal with Takeda

  • for BioVox
  • June 30, 2016

Celyad’s cardiac stem cell treatment fails phase III clinical trials

  • for BioVox
Previous Next

Follow us on

Icon-linkedin Facebook Icon-x Instagram

Stay updated on the latest news!

Subscribe

Want to contact us?

Contact

Interested in our media kit?

Media kit

Stay updated on the latest news!

Subscribe

Want to get in touch?

Contact Us

Follow us on

Icon-linkedin
©2026 BioVox. All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}